14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Oct 14, 2020 $1.80 $1.80 $1.71 $1.72 87 381
Oct 13, 2020 $1.76 $1.76 $1.68 $1.73 254 413
Oct 12, 2020 $1.82 $1.83 $1.76 $1.76 206 982
Oct 09, 2020 $1.78 $1.84 $1.78 $1.80 128 164
Oct 08, 2020 $1.87 $1.90 $1.80 $1.80 272 021
Oct 07, 2020 $1.86 $1.94 $1.86 $1.86 148 174
Oct 06, 2020 $1.89 $1.95 $1.84 $1.85 142 215
Oct 05, 2020 $1.83 $1.91 $1.80 $1.87 123 362
Oct 02, 2020 $1.76 $1.85 $1.76 $1.84 123 644
Oct 01, 2020 $1.82 $1.86 $1.77 $1.82 73 911
Sep 30, 2020 $1.88 $1.90 $1.78 $1.80 131 308
Sep 29, 2020 $1.79 $1.92 $1.76 $1.88 315 962
Sep 28, 2020 $1.77 $1.80 $1.74 $1.78 84 639
Sep 25, 2020 $1.68 $1.78 $1.64 $1.75 97 359
Sep 24, 2020 $1.66 $1.75 $1.55 $1.66 236 951
Sep 23, 2020 $1.83 $1.88 $1.62 $1.70 305 441
Sep 22, 2020 $1.86 $1.87 $1.81 $1.82 77 302
Sep 21, 2020 $1.88 $1.91 $1.81 $1.83 261 270
Sep 18, 2020 $2.05 $2.05 $1.91 $1.92 362 927
Sep 17, 2020 $2.03 $2.10 $2.01 $2.02 255 203
Sep 16, 2020 $1.95 $2.11 $1.94 $2.02 340 642
Sep 15, 2020 $2.06 $2.06 $1.92 $1.93 340 853
Sep 14, 2020 $1.93 $2.04 $1.92 $1.99 370 848
Sep 11, 2020 $1.85 $2.03 $1.76 $1.95 828 433
Sep 10, 2020 $1.79 $1.86 $1.74 $1.75 187 982
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT